Which blood pressure medication should be adjusted in a patient with hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing Hypotension in a Patient on Multiple Antihypertensive Medications

The hydralazine 25 mg oral tablet should be discontinued first due to its direct vasodilatory effect and the patient's current hypotensive state (89/68 mmHg, rechecked at 102/70 mmHg). 1

Assessment of Current Blood Pressure Status

The patient is experiencing hypotension with initial readings of 89/68 mmHg followed by 102/70 mmHg after 30 minutes. This represents a significant concern as:

  • Blood pressure below 90/60 mmHg is considered hypotensive
  • The patient is on multiple antihypertensive medications:
    • Amlodipine 5 mg twice daily (calcium channel blocker)
    • Hydralazine 25 mg twice daily (direct vasodilator)
    • Losartan 50 mg twice daily (angiotensin receptor blocker)
    • Metoprolol 25 mg twice daily (beta-blocker)

Prioritizing Medication Adjustments

When managing hypotension in patients on multiple antihypertensive medications, a systematic approach is needed:

  1. First-line adjustment: Discontinue hydralazine

    • Hydralazine is a direct vasodilator that can cause significant hypotension
    • Research shows hydralazine causes a mean BP reduction of 24/9 mmHg when given intravenously 2
    • Even oral hydralazine results in significant BP lowering effects 3
    • Hydralazine has been associated with hypotension as its most common adverse effect 2
  2. Second-line adjustment (if needed):

    • Consider reducing amlodipine from twice daily to once daily
    • Calcium channel blockers can cause peripheral vasodilation and contribute to hypotension
  3. Third-line adjustment (if needed):

    • Reduce losartan dose or frequency
    • According to FDA labeling, losartan starting dose should be 25 mg in patients with possible intravascular depletion 4

Rationale for Hydralazine Discontinuation

Hydralazine is particularly problematic in this hypotensive patient for several reasons:

  • It acts as a direct arterial vasodilator with minimal effect on venous capacitance vessels
  • It can cause reflex tachycardia and fluid retention
  • It has been associated with higher rates of hypotension compared to other antihypertensives 2
  • The European Society of Cardiology guidelines note that hydralazine should be used with caution in patients with symptomatic orthostatic hypotension 5

Monitoring After Medication Adjustment

After discontinuing hydralazine:

  • Monitor blood pressure every 4-6 hours for the first 24 hours
  • If blood pressure remains low (<100/70 mmHg), consider further medication adjustments
  • If blood pressure normalizes (>120/70 mmHg), maintain current regimen without hydralazine
  • Check electrolytes, particularly potassium, as the patient is on multiple agents affecting the renin-angiotensin-aldosterone system

Important Considerations

  • Avoid abrupt discontinuation of beta-blockers (metoprolol): This can lead to rebound hypertension and tachycardia
  • Monitor for orthostatic changes: Have the patient change positions slowly and monitor for dizziness
  • Consider underlying causes: Evaluate for other causes of hypotension such as dehydration, infection, or cardiac issues
  • Medication timing: If hypotension is more pronounced at certain times of day, consider adjusting the timing of remaining antihypertensive medications

Pitfalls to Avoid

  • Do not discontinue multiple antihypertensive medications simultaneously: This can lead to rebound hypertension
  • Do not ignore recurrent hypotension: If hypotension persists after hydralazine discontinuation, further medication adjustments will be necessary
  • Avoid combining RAS blockers: The patient is already on losartan; adding an ACE inhibitor would increase hypotension risk 5
  • Do not maintain the same regimen: Continuing all current medications despite documented hypotension could lead to falls, syncope, or end-organ damage

By discontinuing hydralazine first, you address the most likely contributor to hypotension while maintaining the core antihypertensive regimen that may be necessary for the patient's underlying conditions.

References

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.